Progesterone and its derivatives are neuroprotective agents in experimental diabetic neuropathy: A multimodal analysis

[1]  K. Balasubramanian,et al.  Influence of streptozotocin-induced diabetes and insulin treatment on the pituitary-testicular axis during sexual maturation in rats. , 2012, Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association.

[2]  M. Tena-Sempere,et al.  Expression of Hypothalamic KiSS-1 System and Rescue of Defective Gonadotropic Responses by Kisspeptin in Streptozotocin-Induced Diabetic Male Rats , 2006, Diabetes.

[3]  L. Garcia-Segura,et al.  Neuroactive steroids prevent peripheral myelin alterations induced by diabetes , 2006, Neuroscience Letters.

[4]  L. Garcia-Segura,et al.  Sex‐dimorphic effects of progesterone and its reduced metabolites on gene expression of myelin proteins by rat Schwann cells , 2006, Journal of the peripheral nervous system : JPNS.

[5]  F. Montorsi,et al.  Sexual function and endocrine profile in fertile women with type 1 diabetes. , 2006, Diabetes care.

[6]  A. Mensah-Nyagan,et al.  Effect of streptozotocin-induced diabetes on the gene expression and biological activity of 3β-hydroxysteroid dehydrogenase in the rat spinal cord , 2005, Neuroscience.

[7]  M. Schumacher,et al.  Ro5-4864, a synthetic ligand of peripheral benzodiazepine receptor, reduces aging-associated myelin degeneration in the sciatic nerve of male rats , 2005, Mechanisms of Ageing and Development.

[8]  D. Garris.  Gonadal steroid modulation of the diabetes (db/db) mutation-induced hyperlipometabolic, hypogonadal syndrome: restoration of female reproductive tract cytochemical and structural indices. , 2005, Pathophysiology : the official journal of the International Society for Pathophysiology.

[9]  G. Nicolini,et al.  Intraepidermal nerve fiber density in rat foot pad: neuropathologic–neurophysiologic correlation , 2005, Journal of the peripheral nervous system : JPNS.

[10]  L. Doncarlos,et al.  Glia-neuron crosstalk in the neuroprotective mechanisms of sex steroid hormones , 2005, Brain Research Reviews.

[11]  M. Vranic,et al.  Insulin alone increases hypothalamo-pituitary-adrenal activity, and diabetes lowers peak stress responses. , 2005, Endocrinology.

[12]  Nish Chaturvedi,et al.  Vascular risk factors and diabetic neuropathy. , 2005, The New England journal of medicine.

[13]  S. Li,et al.  Impact of neuropathic pain on the gene expression and activity of cytochrome P450side-chain-cleavage in sensory neural networks , 2004, Cellular and Molecular Life Sciences CMLS.

[14]  B. Howard,et al.  Effect of oestrogen plus progestin on the incidence of diabetes in postmenopausal women: results from the Women’s Health Initiative Hormone Trial , 2004, Diabetologia.

[15]  S. Mellon,et al.  Niemann–Pick type C disease involves disrupted neurosteroidogenesis and responds to allopregnanolone , 2004, Nature Medicine.

[16]  P. Ghezzi,et al.  Erythropoietin both protects from and reverses experimental diabetic neuropathy. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[17]  L. Nobbio,et al.  Mifepristone (RU 38486) influences expression of glycoprotein Po and morphological parameters at the level of rat sciatic nerve: in vivo observations , 2003, Experimental Neurology.

[18]  K. Nave,et al.  Therapeutic administration of progesterone antagonist in a model of Charcot-Marie-Tooth disease (CMT-1A) , 2003, Nature Medicine.

[19]  L. Garcia-Segura,et al.  Progesterone and its derivatives dihydroprogesterone and tetrahydroprogesterone reduce myelin fiber morphological abnormalities and myelin fiber loss in the sciatic nerve of aged rats , 2003, Neurobiology of Aging.

[20]  D. Pareyson,et al.  Axonal swellings predict the degeneration of epidermal nerve fibers in painful neuropathies , 2003, Neurology.

[21]  U. Suter,et al.  Disease mechanisms in inherited neuropathies , 2003, Nature Reviews Neuroscience.

[22]  M. Schumacher,et al.  Steroid hormones and neurosteroids in normal and pathological aging of the nervous system , 2003, Progress in Neurobiology.

[23]  L. Garcia-Segura,et al.  Aromatase: a neuroprotective enzyme , 2003, Progress in Neurobiology.

[24]  J. A. Peters,et al.  Neurosteroid modulation of GABAA receptors , 2003, Progress in Neurobiology.

[25]  J. Dekker,et al.  Steroids in adult men with type 1 diabetes: a tendency to hypogonadism. , 2003, Diabetes care.

[26]  C. Mathieu,et al.  Progesterone in gestational diabetes mellitus: guilty or not guilty? , 2003, Trends in Endocrinology & Metabolism.

[27]  D. Wright,et al.  Restorative effects of neurotrophin treatment on diabetes-induced cutaneous axon loss in mice , 2003, Experimental Neurology.

[28]  M. Schumacher,et al.  Progesterone Neuroprotection in the Wobbler Mouse, a Genetic Model of Spinal Cord Motor Neuron Disease , 2002, Neurobiology of Disease.

[29]  E. Davidson,et al.  Effect of treatment of diabetic rats with dehydroepiandrosterone on vascular and neural function. , 2002, American journal of physiology. Endocrinology and metabolism.

[30]  M. Vranic,et al.  Diabetes impairs hypothalamo-pituitary-adrenal (HPA) responses to hypoglycemia, and insulin treatment normalizes HPA but not epinephrine responses. , 2002, Diabetes.

[31]  M. Schumacher,et al.  Cellular basis for progesterone neuroprotection in the injured spinal cord. , 2002, Journal of neurotrauma.

[32]  L. Martini,et al.  Neuroactive steroids and peripheral myelin proteins , 2001, Brain Research Reviews.

[33]  J. Olerud,et al.  Color Subtractive–Computer-assisted Image Analysis for Quantification of Cutaneous Nerves in a Diabetic Mouse Model , 2001, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

[34]  N. Matsumoto,et al.  IMPAIRED TESTICULAR FUNCTION IN RATS WITH DIET-INDUCED HYPERCHOLESTEROLEMIA AND/OR STREPTOZOTOCIN-INDUCED DIABETES MELLITUS , 2001, Endocrine research.

[35]  R. Fitzgerald,et al.  Quantification of neurosteroids in rat plasma and brain following swim stress and allopregnanolone administration using negative chemical ionization gas chromatography/mass spectrometry. , 2000, Analytical biochemistry.

[36]  K. Sugimoto,et al.  Diabetic neuropathy – a continuing enigma , 2000, Diabetes/metabolism research and reviews.

[37]  N. Calcutt,et al.  Protection of Sensory Function and Antihyperalgesic Properties of a Prosaposin-derived Peptide in Diabetic Rats , 2000, Anesthesiology.

[38]  J. Bronstein.  Function of tetraspan proteins in the myelin sheath , 2000, Current Opinion in Neurobiology.

[39]  L. Sebastiani,et al.  The action of steroid hormones on peripheral myelin proteins: A possible new tool for the rebuilding of myelin? , 2000, Journal of neurocytology.

[40]  H. Nagaraja,et al.  Painful sensory neuropathy , 1999, Neurology.

[41]  D. D'urso,et al.  Progesterone derivatives are able to influence peripheral myelin protein 22 and P0 gene expression: Possible mechanisms of action , 1999, Journal of neuroscience research.

[42]  G. Biessels,et al.  Neurophysiological changes in the central and peripheral nervous system of streptozotocin-diabetic rats. Course of development and effects of insulin treatment. , 1999, Brain : a journal of neurology.

[43]  M. Schumacher,et al.  Progesterone Stimulates the Activity of the Promoters of Peripheral Myelin Protein‐22 and Protein Zero Genes in Schwann Cells , 1998, Journal of neurochemistry.

[44]  A. Gintzler,et al.  Gestational and ovarian sex steroid antinociception: synergy between spinal κ and δ opioid systems , 1998, Brain Research.

[45]  R. Melcangi,et al.  Age-induced decrease of glycoprotein Po and myelin basic protein gene expression in the rat sciatic nerve. Repair by steroid derivatives 1 This paper is dedicated to Prof. Béla Halasz, on the occasion of his 70th birthday. 1 , 1998, Neuroscience.

[46]  E. Berry.  Dietary fatty acids in the management of diabetes mellitus. , 1997, The American journal of clinical nutrition.

[47]  S. Yagihashi.  Nerve structural defects in diabetic neuropathy: do animals exhibit similar changes? , 1997 .

[48]  A. Gintzler,et al.  Involvement of spinal cord δ opiate receptors in the antinociception of gestation and its hormonal simulation , 1997, Brain Research.

[49]  M. Schumacher,et al.  Progesterone synthesis and myelin formation by Schwann cells , 1995 .

[50]  M. Cotter,et al.  The relationship of vascular changes to metabolic factors in diabetes mellitus and their role in the development of peripheral nerve complications. , 1994, Diabetes/metabolism reviews.

[51]  E. Scarpini,et al.  Decrease of nerve Na+,K+-ATPase activity in the pathogenesis of human diabetic neuropathy , 1993, Journal of the Neurological Sciences.

[52]  V. Babichev,et al.  Disturbance of neuroendocrine regulation of sexual behavior of male rats with streptozotocin diabetes , 1993, Neuroscience and Behavioral Physiology.

[53]  P. Marini,et al.  ATPase Activity Defects in Alloxan-Induced Diabetic Sciatic Nerve Recovered by Ganglioside Treatment , 1988, Diabetes.

[54]  T. Vilén,et al.  Nerve glucose, fructose, sorbitol, myo-inositol, and fiber degeneration and regeneration in diabetic neuropathy. , 1988, The New England journal of medicine.

[55]  P. Chomczyński,et al.  Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. , 1987, Analytical biochemistry.

[56]  Oliver H. Lowry,et al.  Protein measurement with the Folin phenol reagent. , 1951, The Journal of biological chemistry.

[57]  V. Babichev,et al.  Neuroendocrine control of the gonadotropic function of the hypophysis in experimental diabetes , 2006, Neuroscience and Behavioral Physiology.

[58]  G. Cavaletti,et al.  Experimental cisplatin neuronopathy in rats and the effect of retinoic acid administration , 2004, Journal of Neuro-Oncology.

[59]  L. Eckersley.  Role of the Schwann cell in diabetic neuropathy. , 2002, International review of neurobiology.

[60]  R. Melcangi,et al.  Formation and effects of neuroactive steroids in the central and peripheral nervous system. , 2001, International review of neurobiology.

[61]  N. Christeff,et al.  Basal concentrations of various steroids in the nonobese diabetic (NOD) mouse and effect of immobilization stress. , 1998, Autoimmunity.

[62]  J. Eichberg,et al.  Effects of hypoxia and severity of diabetes on Na,K-ATPase activity and arachidonoyl-containing glycerophospholipid molecular species in nerve from streptozotocin diabetic rats. , 1997, Journal of the peripheral nervous system : JPNS.

[63]  M. Elhilali,et al.  The effect of diabetes on sexual behavior and reproductive tract function in male rats. , 1993, The Journal of urology.

[64]  G. Mazzocchi,et al.  Morphology and functional responses of isolated zona glomerulosa cells of streptozotocin-induced diabetic rats. , 1990, Experimental pathology.

[65]  G. Mazzocchi,et al.  Streptozotocin-induced experimental diabetes causes a time-dependent inhibition of growth and steroidogenic capacity of rat adrenal zona glomerulosa , 1990, Research in experimental medicine. Zeitschrift fur die gesamte experimentelle Medizin einschliesslich experimenteller Chirurgie.

[66]  D. Greene,et al.  Pathogenesis of diabetic neuropathy: role of altered phosphoinositide metabolism. , 1989, Critical reviews in neurobiology.

[67]  0163-769X/04/$20.00/0 Endocrine Reviews 25(4):612–628 Printed in U.S.A. Copyright © 2004 by The Endocrine Society doi: 10.1210/er.2003-0019 Oxidative Stress in the Pathogenesis of , 2022 .

[68]  M. Vranic,et al.  Molecular regulation of the hypothalamo-pituitary-adrenal axis in streptozotocin-induced diabetes: effects of insulin treatment. , 2001, Endocrinology.